desipramine has been researched along with sk&f 81297 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ainsworth, K; Sharp, T; Smith, SE | 1 |
| Barnum, CJ; Bishop, C; Dupre, KB; Eskow, KL | 1 |
| Cantrup, R; Rajakumar, N; Rushlow, WJ; Scornaiencki, R | 1 |
3 other study(ies) available for desipramine and sk&f 81297
| Article | Year |
|---|---|
Repeated administration of fluoxetine, desipramine and tranylcypromine increases dopamine D2-like but not D1-like receptor function in the rat.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Apomorphine; Behavior, Animal; Benzazepines; Desipramine; Dopamine Agonists; Fluoxetine; Male; Phenethylamines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Tranylcypromine | 1998 |
Striatal 5-HT1A receptor stimulation reduces D1 receptor-induced dyskinesia and improves movement in the hemiparkinsonian rat.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic Agents; Animals; Benzazepines; Biogenic Monoamines; Brain Chemistry; Chromatography, High Pressure Liquid; Corpus Striatum; Desipramine; Disease Models, Animal; Dopamine Agonists; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Functional Laterality; Male; Movement Disorders; Oxidopamine; Parkinson Disease; Piperazines; Psychomotor Performance; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D1; Serotonin Antagonists; Serotonin Receptor Agonists; Time Factors | 2008 |
Prefrontal cortical D1 dopamine receptors modulate subcortical D2 dopamine receptor-mediated stress responsiveness.
Topics: Animals; Behavior, Animal; Benzazepines; Desipramine; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Infusions, Parenteral; Injections, Intraperitoneal; Locomotion; Male; Nucleus Accumbens; Oxidopamine; Prefrontal Cortex; Quinpirole; Raclopride; Rats; Rats, Sprague-Dawley; Receptor Cross-Talk; Receptors, Dopamine D1; Receptors, Dopamine D2; Schizophrenia; Schizophrenic Psychology; Stress, Psychological; Swimming | 2009 |